Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M248,091Revenue $M51,978Net Margin (%)23.9Z-Score5.1
Enterprise Value $M266,443EPS $1.8Operating Margin %35.0F-Score7
P/E(ttm))20.2Cash Flow Per Share $0Pre-tax Margin (%)31.4Higher ROA y-yY
Price/Book10.610-y EBITDA Growth Rate %6.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %3.9Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-2.9ROA % (ttm)18.0Higher Current Ratio y-yY
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)52.6Less Shares Outstanding y-yN
Payout Ratio %63.0Shares Outstanding M6,847ROI % (ttm)33.6Gross Margin Increase y-yY

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYTweedy Browne 2013-06-30 Sold Out $28.92 - $32.98
($30.92)
$ 36.5118%Sold Out0
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$20.95 - $24.07
($22.41)
$ 36.5163%Reduce -24.31%62,164
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$19.47 - $23.14
($21.16)
$ 36.5172%Add 543.36%4,273,977
RHHBYTweedy Browne 2012-03-31 Reduce-0.04%$21.55 - $22.17
($20.04)
$ 36.5182%Reduce -22.19%82,130
RHHBYVanguard Health Care Fund 2009-03-31 Reduce-0.2%$13.37 - $18.53
($15.95)
$ 36.51129%Reduce -52.1%429,320
RHHBYVanguard Health Care Fund 2008-12-31 Add2.01%$31.33 - $38.5
($35.55)
$ 36.513%Add 95.76%5,113,297
RHHBYPRIMECAP Management 2008-12-31 Sold Out -1.2%$31.33 - $38.5
($35.55)
$ 36.513%Sold Out0
RHHBYPRIMECAP Management 2008-09-30 Buy 1.2%$20.05 - $22.89
($21.5)
$ 36.5170%New holding, 4306500 sh.4,306,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY :

    Quarterly/Annual Reports about RHHBY:

      News about RHHBY:

      Articles On GuruFocus.com
      Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
      Tweedy Browne Global Reports Their Second Quarter Portfolio Jul 18 2014 
      Signature Select Canadian Fund's Top Holdings Jul 02 2014 
      The Tweedy Browne Global Value Fund's Top First Quarter Holdings Apr 22 2014 
      Most Popular International Stocks of Investment Gurus Mar 05 2014 
      John Rogers' Ariel Fund Comments on Roche Feb 28 2014 
      Ariel International Fund & Ariel Global Fund - Healthy Ideas Feb 28 2014 
      Tweedy Browne Global Value’s Top Five Year End Stocks Jan 24 2014 
      Invesco European Growth Fund’s Top Five Jan 09 2014 
      Vanguard Health Care Fund’s Top Third Quarter Holdings Oct 31 2013 

      More From Our Partners
      What You Need to Know About the Roche-InterMune Deal Aug 29 2014 - BENZINGA

      More From Other Websites
      [$$] Last Week Aug 30 2014
      [$$] Review Aug 29 2014
      What You Need to Know About the Roche-InterMune Deal Aug 29 2014
      With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry? Aug 28 2014
      Seragon Pharmaceuticals Inc. Announces Closing of Its Acquisition by Genentech Aug 27 2014
      The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology... Aug 27 2014
      Roche Furthers Immunotherapy Program with SP142 Launch Aug 26 2014
      3 Biotechs Surging Following InterMune Takeover Aug 26 2014
      Biotech ETFs Surge on InterMune-Roche Deal Aug 26 2014
      Stock Market News for August 26, 2014 Aug 26 2014
      Biogen, Celgene In Buy Range; LinkedIn Coming Back Aug 25 2014
      Summer Rally Contiues on Lower Volume Aug 25 2014
      Stocks End Higher; S&P 500 Pulls Back From 2,000 Level Aug 25 2014
      More Biotech Mergers: Roche to Acquire InterMune (ITMN) Aug 25 2014
      Roche’s Merger Bet Outsmarts the Ice Bucket Challenge Aug 25 2014
      Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs Aug 25 2014
      Burger King soars, Amazon buys Twitch, Apple eyes another record close Aug 25 2014
      Harwood Feffer LLP Announces Investigation of Intermune, Inc. Aug 25 2014
      Roche to Boost Respiratory Product Lineup with InterMune Buy Aug 25 2014
      Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research Aug 25 2014

      Add Notes, Comments or Ask Questions

      User Comments

      Steve.dunfield@google
      ReplySteve.dunfield@google - 5 months ago
      Adjust for split?
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK